Departments of Vascular Medicine.
Clinical Epidemiology, Biostatistics and Bioinformatics.
Clin Chem. 2018 Sep;64(9):1308-1318. doi: 10.1373/clinchem.2017.285288. Epub 2018 Jun 14.
In the past decade, the search for circulating microRNA (miRNA) biomarkers has yielded numerous associations between miRNAs and different types of disease. However, many of these relations could not be replicated in subsequent studies under similar experimental conditions. Although this lack of replicability may be explained by the variation in experimental design and analysis methods, guidelines on the most appropriate design and analysis methods to study circulating miRNAs are scarce.
miRNA biomarker experiments generally consist of a discovery phase and a validation phase. In the discovery phase, typically hundreds of miRNAs are measured in parallel to identify candidate biomarkers. Because of the costs of such high-throughput experiments, the number of individuals included in those studies is often too small, which can easily lead to false positives and false negatives. In the validation phase, a small number of identified biomarker candidates are measured in a large cohort of cases and controls, generally by quantitative PCR (qPCR). Although qPCR is a sensitive method to measure miRNAs in the circulation, experimental design and qPCR data analysis remain challenging. Omitting some crucial steps in the design and analysis of the qPCR experiment or performing them incorrectly can cause serious biases, ultimately leading to false conclusions.
In this review, we aim to expose and discuss the most common sources of interstudy variation in miRNA research from a methodological point of view and to provide guidelines on how to perform these steps correctly to increase replicability of studies on circulating miRNAs.
在过去的十年中,人们一直在寻找循环 microRNA(miRNA)生物标志物,以期发现 miRNA 与不同类型疾病之间的诸多关联。然而,在类似的实验条件下,许多这些关联在后续研究中无法得到复制。尽管这种不可复制性可能可以用实验设计和分析方法的差异来解释,但关于研究循环 miRNA 最合适的设计和分析方法的指南却很少。
miRNA 生物标志物实验通常由发现阶段和验证阶段组成。在发现阶段,通常需要同时测量数百个 miRNA 来鉴定候选生物标志物。由于这些高通量实验的成本较高,因此纳入这些研究的个体数量通常太少,这很容易导致假阳性和假阴性。在验证阶段,通过定量 PCR(qPCR)在大量病例和对照中测量少数已确定的生物标志物候选物。尽管 qPCR 是测量循环中 miRNA 的敏感方法,但实验设计和 qPCR 数据分析仍然具有挑战性。如果在 qPCR 实验的设计和分析中省略了一些关键步骤或操作不正确,可能会导致严重的偏差,最终得出错误的结论。
在这篇综述中,我们旨在从方法学的角度揭示和讨论 miRNA 研究中最常见的研究间差异来源,并提供关于如何正确执行这些步骤以提高循环 miRNA 研究可重复性的指南。